Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,700.00
Bid: 2,706.00
Ask: 2,710.00
Change: -10.00 (-0.37%)
Spread: 4.00 (0.148%)
Open: 2,706.00
High: 2,720.00
Low: 2,688.00
Prev. Close: 2,710.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supplementary Base Prospectus dated November 11, 2

11 Nov 2014 13:32

RNS Number : 7275W
Coca-Cola HBC Finance B.V.
11 November 2014
 



 

Coca-Cola HBC Finance B.V.

Guaranteed by Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V.

announce the publication of supplementary prospectus relating to the

EUR 3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V.

 

 

Amsterdam The Netherlands - November 11, 2014 - Coca-Cola HBC Finance B.V., Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V. announce today the publication of the following supplementary prospectus which has been approved by the UK Listing Authority and is available for viewing:

 

Supplementary Prospectus, dated November 11, 2014 to the Base Prospectus dated September 18, 2014, in respect of the €3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V. as issuer and Coca-Cola HBC A.G. and Coca-Cola HBC Holdings B.V. as guarantors (the "Supplementary Prospectus").

 

The Supplementary Prospectus constitutes a supplement for the purposes of Section 87G of the Financial Services and Markets Act 2000 (the "FSMA").This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus dated September 18, 2014. Terms defined in the Base Prospectus have the same meaning when used in this Supplement. The purpose of this Supplement is to incorporate by reference in the Base Prospectus the CCH Group's third quarter results for the period ended 26 September 2014 (the "CCH Group Results").

 

Copies of the CCH Group Results have been filed with the Financial Conduct Authority and, by virtue of this Supplement, the CCH Group Results are incorporated in, and form part of, the Base Prospectus, save that the ninth paragraph on page twelve of the CCH Group Results shall not be deemed to be incorporated in and shall not be deemed to form part of this Supplement.

 

A copy of the Supplementary Prospectus and the CCH Group Results have also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBBBJTMBTBBLI
Date   Source Headline
21st Jun 20245:11 pmRNSTransaction in Own Shares
20th Jun 20245:45 pmRNSTransaction in Own Shares
19th Jun 20245:14 pmRNSTransaction in Own Shares
18th Jun 20245:09 pmRNSTransaction in Own Shares
18th Jun 20244:23 pmRNSDirector/PDMR Shareholding
17th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20247:09 amRNSTransaction in Own Shares
11th Jun 20245:41 pmRNSTransaction in Own Shares
10th Jun 20245:25 pmRNSTransaction in Own Shares
5th Jun 20245:32 pmRNSTransaction in Own Shares
4th Jun 20245:28 pmRNSTransaction in Own Shares
3rd Jun 20245:19 pmRNSTransaction in Own Shares
3rd Jun 20244:11 pmRNSIssue of Equity and total voting rights
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.